Clinical Trials in Luzhou, Sichuan
38 recruiting
Showing 1–20 of 36 trials
Recruiting
Phase 3
IBI363 vs Docetaxel in Patients With Advanced Squamous Lung Cancer After Standard Treatments Have Failed
iO Resistant sqNSCLC
Fortvita Biologics (USA)Inc.600 enrolled44 locationsNCT07217301
Recruiting
Not Applicable
ASCEND-1: Lifestyle Intervention Plus Mazdutide for Weight Management
ObesityWeight Control
Shanghai Zhongshan Hospital420 enrolled13 locationsNCT07517042
Recruiting
Phase 3
A Clinical Study of Neoadjuvant Treatment With TQB2102 for Injection for Human Epidermal Growth Factor Receptor 2 (HER2) Positive Breast Cancer
HER2-positive Breast Cancer
Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co., Ltd.544 enrolled78 locationsNCT07043725
Recruiting
Phase 2
A Clinical Trial of TQH2929 Injection in Patients With Acute Flare-up of Generalized Pustular Psoriasis
Generalized Pustular Psoriasis
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.36 enrolled32 locationsNCT07314060
Recruiting
Phase 2Phase 3
Phase 2 Trial of Adagrasib Monotherapy and in Combination With Pembrolizumab and a Phase 3 Trial of Adagrasib in Combination in Patients With a KRAS G12C Mutation KRYSTAL-7
Advanced Non-Small Cell Lung CancerMetastatic Non Small Cell Lung Cancer
Mirati Therapeutics Inc.806 enrolled764 locationsNCT04613596
Recruiting
An Observational Study to Assess Real-World Use of Upadacitinib Tablets in Adolescent and Adult Participants With Moderate to Severe Atopic Dermatitis in China
Atopic Dermatitis
AbbVie1,000 enrolled38 locationsNCT06421740
Recruiting
Phase 1Phase 2
Clinical Trial Evaluating TQB6411 Injection in Subjects With Esophageal Cancer
Esophageal Cancer
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.105 enrolled30 locationsNCT07367516
Recruiting
Phase 1
A Clinical Trial on the Safety, Tolerability, Pharmacokinetics and Preliminary Efficacy of TQB3019 Capsule in Subjects With Advanced Malignant Tumors
Advanced Malignant Cancer
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.80 enrolled15 locationsNCT06943677
Recruiting
Phase 3
TQB2930 Injection for the Treatment of HER2-positive Advanced Breast Cancer
HER2-positive Advanced Breast Cancer
Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co., Ltd.416 enrolled69 locationsNCT07047365
Recruiting
Phase 1Phase 2
Clinical Trial of TQB2825 Injection Combined Immunochemotherapy in Subjects With Diffuse Large B Cell Lymphoma
Diffuse Large B Cell Lymphoma
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.90 enrolled25 locationsNCT06829771
Recruiting
Phase 3
Clinical Trial Comparing TQB2868 Injection Combined With Anlotinib Hydrochloride Capsules With Placebo Combined With Chemotherapy as First-line Treatment for Metastatic Pancreatic Ductal Adenocarcinoma (mPDAC)
Metastatic Pancreatic Ductal Adenocarcinoma
Shanghai Chia Tai Tianqing Pharmaceutical Technology Development Co., Ltd.566 enrolled70 locationsNCT07165951
Recruiting
Phase 1Phase 2
A Study to Assess the Safety, Pharmacokinetics, and Anti-Tumor Activity of Oral HP518 in mCRPC Patients
Metastatic Castration-resistant Prostate Cancer
Hinova Pharmaceuticals Inc.84 enrolled27 locationsNCT06155084
Recruiting
Phase 2
F573 for Injection for the Treatment of Liver Injury/Failure
Acute-On-Chronic Liver FailureAcute Liver Failure
Beijing Continent Pharmaceutical Co, Ltd.97 enrolled10 locationsNCT05689645
Recruiting
Not Applicable
Effectiveness of an AI-Enabled Stratified Management System for Premature Coronary Artery Disease
Premature Coronary Heart Disease
China National Center for Cardiovascular Diseases4,900 enrolled16 locationsNCT07031531
Recruiting
Not Applicable
Treatment of Vasospasm of Aneurysmal Subarachnoid Hemorrhage With Intrathecal Nicardipine - FAST-IT Trial
Aneurysmal Subarachnoid HemorrhageVasospasm
The Affiliated Hospital Of Guizhou Medical University396 enrolled28 locationsNCT06329635
Recruiting
Not Applicable
Comparing the Efficacy and Safety Between Continuous Subcutaneous Beinaglutide and CSII for Newly Diagnosed T2DM Patients
T2DMT2DM (Type 2 Diabetes Mellitus)Type 2 Diabetic Patients
Beijing Hospital115 enrolled16 locationsNCT03987308
Recruiting
Phase 1
Study of HRS-1167 as Monotherapy in Patients With Advanced Solid Tumors
Advanced Solid Tumors
Jiangsu HengRui Medicine Co., Ltd.153 enrolled20 locationsNCT05473624
Recruiting
Phase 2
Qinqiao Yan Shu Granules for the Treatment of Acute Pharyngitis (Exterior Wind-Heat Syndrome) Phase II Clinical Trial
Acute Pharyngitis
Jianmin Pharmaceutical Group Co., LTD.216 enrolled7 locationsNCT06932328
Recruiting
Phase 2
Clinical Trial of TQB2825 Injection Combined With Chemotherapy in Subjects With Diffuse Large B-cell Lymphoma
Diffuse Large Cell B-lymphoma
Shanghai Chia Tai Tianqing Pharmaceutical Technology Development Co., Ltd.55 enrolled24 locationsNCT06854445
Recruiting
Phase 4
China Stroke Primary Prevention Trial 2 for Participants With H-type Hypertension and MTHFR 677 CC/CT Genotype (CSPPT2-CC/CT)
HypertensionMTHFR 677 CC or CT GenotypeElevated Plasma Homocysteine (Hcy≥10µmol/L)+1 more
Shenzhen Ausa Pharmed Co.,Ltd32,000 enrolled20 locationsNCT04974138